63 research outputs found
Do Soup Kitchen Meals Contribute to Suboptimal Nutrient Intake & Obesity in the Homeless Population?
No full textThe double burden of suboptimal nutrient intake and obesity exists when available foods lack essential nutrients to promote health and provide high amounts of energy. This study evaluated the nutrition content of 41 meals served to the homeless at 3 urban soup kitchens. The mean nutrient content of all meals and of meals from each of the kitchens was compared to two-thirds of the estimated average requirement (EAR). The mean nutrient content of the meals did not provide two-thirds of the EAR for energy, vitamin C, magnesium, zinc, dietary fiber, or calcium but provided 11.8% of calories from saturated fat. On average one meal did not meet homeless individuals’ estimated requirements; however, 2 meals did meet estimated requirements but provided inadequate fiber and high amounts of energy, saturated fat, and sodium. Soup kitchen meals may contribute to the high prevalence of obesity and chronic disease reported in the homeless, food insecure population
Letter from Henry R. Jackson, of Georgia, to ex-Senator Allen G. Thurman : with explanatory papers.
No full textThis pamphlet is a reply to criticism by Senator Thurman of an address delivered by the author before the Confederate Veterans at Macon, Georgia, October 26, 1887--Pref. p. [2]Mode of access: Internet
Food Recovery Program at Farmers’ Markets Increases Access to Fresh Fruits and Vegetables for Food Insecure Individuals
No full textFood recovery programs are an increasingly popular method to decrease the amount of food waste in the United States while increasing healthy food access for food insecure individuals. One such program is the Heartside Gleaning Initiative that began in 2014 in Grand Rapids, Michigan. The program partners with low-income volunteers to collect fresh produce from farmers’ markets for redistribution. From June to October 2014, 17,000 pounds of fresh produce was provided to low-income individuals and food pantries. A survey of participants indicated high usage of the produce and high satisfaction with the gleaning program. This program confirms that gleaning is a viable method of reducing barriers to accessing produce for food pantries and food insecure individuals
Identifying Gaps in Curriculum with the Identified Knowledge, Skills and Abilities Important to Hospitality and Tourism Management Graduates
No full textHospitality and Tourism Management curricula aligned with the knowledge, skills and abilities (KSAs) necessary for success will properly prepare students to meet industry expectations. Hospitality and tourism programs are increasing in number and popularity, with degrees offered by two-year and four-year colleges, as part of business schools, and as stand-alone programs. Many programs have a similar core curriculum with courses in business management, accounting, finance, human resource management, hospitality law, information technology, and marketing. Some programs allow specialization in one of the traditional areas of hospitality such as food and beverage, lodging, tourism, recreation, or event management. In addition, an internship is often required.
Due to the broad scope of positions open to hospitality students upon graduation, it is difficult to determine which KSAs are important to all or most graduates, and how these KSAs differ from those taught in traditional business programs. Moreover, the teaching of some core areas, such as information technology, is problematic due to rapid advances in the field, non-standardization of the technology and the high cost of software (Mandabach, VanLeeuwen, & Bloomquist, 2001). Soft topics, such as teamwork, listening skills, verbal and written communication skills, and professionalism are often given short shrift in curriculum development but are given high rankings of importance by both recent graduates and upper level managers (Tesone & Ricci, 2006)
The Sensitivity of Daily Temperature Variability and Extremes to Dataset Choice
No full textAbstractRobust conclusions regarding changes in the temperature distribution rely on the accuracy and reliability of the input datasets used. Differences between methodologies and datasets in previous studies add uncertainty when comparing and quantifying findings. Here, the authors investigate the sensitivity of assessing global and regional temperature variability and extremes over 1980–2014 in gridded datasets of daily temperature anomalies. A gridded in situ–based dataset, Hadley Centre Global Historical Climatology Network–Daily (HadGHCND), is compared against several commonly used reanalysis products by assessing both the entire distribution and the tails of the distribution. Empirical probability distribution functions show sensitivity to the input dataset when estimating aspects such as standard deviation and skewness, with the mean showing robust results for most regions, irrespective of dataset choice. Standard deviation is especially sensitive, with larger disagreements between datasets for some regions more than others, such as Africa and the Mediterranean region, and with larger differences in minimum temperatures compared with maximum temperatures. Estimates of extreme parameters also show sensitivity to dataset choice, particularly in the lower tails and for daily minimum temperature anomalies. Comparing changes in the means and the extremes of the temperature distributions, the cold extremes in the lower tails have been warming at a faster rate than the mean of the entire distribution for much of the Northern Hemisphere extratropics, with warm extremes warming at a faster rate than the mean in some subtropical regions. These documented sensitivities call for caution when assessing changes in temperature variability and extremes, as dataset choice can have substantial effects on results.</jats:p
DNA vaccines: a review
No full textPT: S; CR: ABBAS AK, 1997, CELLULAR MOL IMMUNOL ALLGOOD VE, 1997, BIOCHEMISTRY-US, V36, P224 ALPAR HO, 1997, BIOCHEM SOC T, V25, S337 ANDERSON ED, 1996, MOL MAR BIOL BIOTECH, V5, P114 ANDERSON R, 1996, INFECT IMMUN, V64, P3168 ANDERSON RGW, 1992, SCIENCE, V255, P410 ANDREW ME, 1990, J VIROL, V64, P4776 ATANASIU P, 1962, ACAD SCI, V254, P4228 AUSTYN JM, 1996, J EXP MED, V183, P1287 BACHMANN MF, 1994, EUR J IMMUNOL, V24, P2567 BACHMANN MF, 1996, J EXP MED, V183, P2259 BACHMANN MF, 1997, SCIENCE, V276, P2024 BAKER A, 1997, NUCLEIC ACIDS RES, V25, P1950 BAN EM, 1997, VACCINE, V15, P811 BARRY MA, 1995, NATURE, V377, P632 BARRY MA, 1997, VACCINE, V15, P788 BENNET RM, 1988, J IMMUNOL, V140, P2937 BENNETT RM, 1985, J CLIN INVEST, V76, P2182 BENNETT RM, 1987, J EXP MED, V166, P850 BERNFIELD C, 1997, BIOCHEM SOC T, V25, S335 BIRD AP, 1987, TRENDS GENET, V3, P342 BOS JD, 1993, IMMUNOL TODAY, V14, P75 BOT A, 1996, VIRAL IMMUNOL, V9, P207 BOYER JD, 1997, NAT MED, V3, P526 BRAUN R, 1997, VACCINE RES, V6, P151 CARDOSO AI, 1996, VIROLOGY, V225, P293 CARSON DA, 1997, J EXP MED, V186, P1621 CASARES S, 1997, J EXP MED, V186, P1481 CASSELL DJ, 1994, J EXP MED, V180, P1829 CHATTERGOON M, 1997, FASEB J, V11, P753 CHOW YH, 1997, J VIROL, V71, P169 CHU RS, 1997, J EXP MED, V186, P1623 CLARKE NJ, 1997, IMMUNOTECHNOLOGY, V3, P145 COHEN J, 1995, SCIENCE, V270, P908 CONDON C, 1996, NAT MED, V2, P1122 CONRY RM, 1996, GENE THER, V3, P67 CORR M, 1996, J EXP MED, V184, P1555 COX GJM, 1993, J VIROL, V67, P5664 COX JC, 1997, VACCINE, V15, P248 CURIEL DT, 1991, P NATL ACAD SCI USA, V88, P8850 DALSGAARD K, 1990, ADV VET SCI COMP MED, V35, P121 DAMBROSIO D, 1995, SCIENCE, V268, P293 DANKO I, 1994, VACCINE, V12, P1499 DARJI A, 1998, CELL CAMBRIDGE MASS, V91, P765 DAVIS HL, 1996, BIOTECHNIQUES, V21, P93 DAVIS HL, 1997, GENE THER, V4, P181 DECK RR, 1997, VACCINE, V15, P71 DEMPSEY PW, 1996, SCIENCE, V271, P348 DIETRICH G, 1998, NAT BIOTECHNOL, V16, P181 DIPELLEGRINO G, 1997, NATURE, V388, P729 DOLIVEIRA C, 1997, VACCINE, V15, P1796 ELDRIDGE JH, 1989, CURR TOP MICROBIOL, V146, P59 ETCHART N, 1997, J GEN VIROL 7, V78, P1577 EVERSON MP, 1996, J LEUKOCYTE BIOL, V59, P494 FASBENDER A, 1997, J BIOL CHEM, V272, P6479 FELTQUATE DM, 1997, J IMMUNOL, V158, P2278 FERKOL T, 1995, J CLIN INVEST, V95, P493 FOMSGAARD A, 1995, UGESKRIFT LAEGER, V157, P4932 FORSTHUBER T, 1996, SCIENCE, V271, P1728 FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478 GAO Y, 1995, VACCINE, V13, P871 GEISSLER M, 1997, J IMMUNOL, V158, P1231 GERLONI M, 1997, NAT BIOTECHNOL, V15, P876 GERRITSEN ME, 1993, FASEB J, V7, P523 GILKESON GS, 1989, J IMMUNOL, V142, P1482 GILKESON GS, 1993, CLIN IMMUNOL IMMUNOP, V68, P283 GILKESON GS, 1995, J CLIN INVEST, V95, P1398 GOULDFOGERITE S, 1996, J LIPOS RES, V6, P357 GREGORIADIS G, 1997, FEBS LETT, V402, P107 GUERY JC, 1995, J IMMUNOL, V154, P536 GUERY JC, 1996, J EXP MED, V183, P751 GUPTA RK, 1993, VACCINE, V11, P293 HALPERN MD, 1996, CELL IMMUNOL, V167, P72 HARTIKKA J, 1996, HUM GENE THER, V7, P1205 HASSETT DE, 1997, J VIROL, V71, P7881 HAYNES JR, 1996, J BIOTECHNOL, V44, P37 HENGEL H, 1997, CURR OPIN IMMUNOL, V9, P470 HERGERSBERG M, 1991, EXPERIENTIA, V47, P1171 HERMANN JE, 1996, J INFECT DIS S1, V174, S93 HOHLFELD R, 1994, IMMUNOL TODAY, V15, P269 HUGHES HPA, 1992, VACCINE, V10, P226 HUYGEN K, 1996, NAT MED, V2, P893 IJAZ MK, 1991, J VIROL, V65, P3106 INCHAUSPE G, 1997, DNA CELL BIOL, V16, P185 IRVINE KR, 1996, J IMMUNOL, V156, P238 ISHIZAKA ST, 1995, J INFECT DIS, V172, P1108 IWASAKI A, 1997, J IMMUNOL, V158, P4591 JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11 JONES DH, 1997, VACCINE, V15, P814 KAWABATA K, 1995, PHARMACEUT RES, V12, P825 KELLER ET, 1996, CANCER GENE THER, V3, P186 KENNEDY RC, 1997, NAT MED, V3, P501 KIM JJ, 1997, J IMMUNOL, V158, P816 KIMURA Y, 1994, J BIOCHEM, V116, P991 KLAVINSKIS LS, 1997, VACCINE, V15, P818 KLINMAN DM, 1996, P NATL ACAD SCI USA, V93, P2879 KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243 KRIEG AM, 1995, NATURE, V374, P546 KRIEG AM, 1996, TRENDS MICROBIOL, V4, P73 KRIEG AM, 1998, TRENDS MICROBIOL, V6, P23 KRIEGER M, 1993, J BIOL CHEM, V268, P4569 KUKLIN N, 1997, J VIROL, V71, P3138 LEPOTIER MF, 1997, VET MICROBIOL, V55, P75 LERNER RA, 1971, P NATL ACAD SCI USA, V68, P1212 LEW D, 1995, HUM GENE THER, V6, P553 LEWIS PJ, 1997, VACCINE, V15, P861 LI LN, 1995, NAT MED, V1, P705 LIU Y, 1997, NAT BIOTECHNOL, V15, P167 LOMOTAN EA, 1997, VACCINE, V15, P1959 LUTZ MB, 1996, EUR J IMMUNOL, V26, P586 MACDONALDS LJ, 1992, VET MED, V87, P223 MAECKER HT, 1997, VACCINE, V15, P1687 MANCINI M, 1996, P NATL ACAD SCI USA, V93, P12496 MANICKAN E, 1995, J IMMUNOL, V155, P259 MANICKAN E, 1997, CRIT REV IMMUNOL, V17, P139 MANICKAN E, 1997, J LEUKOCYTE BIOL, V61, P125 MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991 MONTEIL M, 1996, VET RES, V27, P443 MOR G, 1995, J IMMUNOL, V155, P2089 MOR G, 1996, J CLIN INVEST, V98, P2700 MOR G, 1997, HUM GENE THER, V8, P293 MOSMANN TR, 1996, IMMUNOL TODAY, V17, P138 NEUBERGER MS, 1997, CELL, V90, P971 NICHOLS WW, 1995, ANN NY ACAD SCI, V772, P30 OHAGAN DT, 1993, VACCINE, V11, P149 PARDOLL DM, 1995, IMMUNITY, V3, P165 PERTMER TM, 1995, VACCINE, V13, P1427 PERTMER TM, 1996, J VIROL, V70, P6119 PISETSKY DS, 1996, IMMUNITY, V5, P303 PISETSKY DS, 1996, J IMMUNOL, V156, P421 PISETSKY DS, 1997, NAT MED, V3, P829 PUYAL C, 1995, EUR J BIOCHEM, V228, P697 RAVETCH JV, 1997, CURR OPIN IMMUNOL, V9, P121 RAZ E, 1993, P NATL ACAD SCI USA, V90, P4523 RAZ E, 1994, P NATL ACAD SCI USA, V91, P9519 RAZ E, 1996, P NATL ACAD SCI USA, V93, P5141 RICHARDSON J, 1997, J VIROL, V71, P9640 RIDGE JP, 1996, SCIENCE, V271, P1723 ROBERTSON JS, 1994, VACCINE, V12, P1526 ROBINSON HL, 1997, SEMIN IMMUNOL, V9, P271 ROBINSON HL, 1997, VACCINE, V15, P785 ROMAN M, 1997, NAT MED, V3, P849 ROMANI N, 1989, J EXP MED, V169, P1169 ROOK GAW, 1998, IMMUNOL TODAY, V19, P113 ROTHEL JS, 1997, IMMUNOL CELL BIOL, V75, P41 RUSSELL JL, 1978, P NATL ACAD SCI USA, V75, P6211 SALLBERG M, 1997, J VIROL, V71, P5295 SALLUSTO F, 1994, J EXP MED, V179, P1109 SATO Y, 1996, SCIENCE, V273, P352 SCHRIJVER RS, 1997, VACCINE, V15, P1908 SCHRODER JM, 1995, J INVEST DERMATOL S, V105, S20 SCHUBBERT R, 1997, P NATL ACAD SCI USA, V94, P961 SCHWARZENBERGER P, 1997, J VIROL, V71, P8563 SISSON S, 1963, ANATOMY DOMESTIC ANI SIZEMORE DR, 1995, SCIENCE, V270, P299 SIZEMORE DR, 1997, VACCINE, V15, P804 SNAPPER CM, 1987, SCIENCE, V236, P944 SNAPPER CM, 1993, IMMUNOL TODAY, V14, P15 SONEHARA K, 1996, J INTERF CYTOK RES, V16, P799 SPARWASSER T, 1997, EUR J IMMUNOL, V27, P1671 SPECIALE J, 1993, COMP CONT EDUC PRACT, V15, P1071 STEINBERG AD, 1990, IMMUNOL REV, V118, P129 STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271 STEINMAN RM, 1997, IMMUNOL REV, V156, P25 SUN SQ, 1997, J IMMUNOL, V159, P3119 SUNDARAM P, 1997, VACCINE, V15, P664 SURADHAT S, 1997, VIRAL IMMUNOL, V10, P117 SYRENGELAS AD, 1996, NAT MED, V2, P1038 TANG DC, 1992, NATURE, V356, P152 TAUBES G, 1997, SCIENCE, V278, P1711 TEMPLETON NS, 1997, NAT BIOTECHNOL, V15, P647 TIGELAAR RE, 1995, J INVEST DERMATOL, V105, P438 TOKUNAGA T, 1984, J NATL CANCER I, V72, P955 TORRES CAT, 1997, J IMMUNOL, V158, P4529 TRIYATNI M, 1998, J VIROL, V72, P84 TSUJI T, 1997, J IMMUNOL, V158, P4008 ULMER JB, 1993, SCIENCE, V259, P1745 ULMER JB, 1996, IMMUNOLOGY, V89, P59 ULMER JB, 1996, MUCOSAL VACCINES, P119 ULMER JB, 1996, TRENDS MICROBIOL, V4, P169 VANDERLUGT CJ, 1996, CURR OPIN IMMUNOL, V8, P831 VANDRUNENLITTLE.S, 1998, J GEN VIROL, V79, P831 VOLCHKOV VE, 1992, FEBS LETT, V305, P181 WAGNER E, 1992, P NATL ACAD SCI USA, V89, P6099 WAINE GJ, 1995, PARASITOL TODAY, V11, P113 WAISMAN A, 1996, NAT MED, V2, P899 WANG B, 1997, VACCINE, V15, P821 WANG CY, 1989, BIOCHEMISTRY-US, V28, P9508 WANG LF, 1996, J IMMUNOL, V156, P4079 WANG YJ, 1997, VIROLOGY, V228, P278 WHALEN RG, 1995, CLIN IMMUNOL IMMUNOP, V75, P1 WHEELER CJ, 1996, P NATL ACAD SCI USA, V93, P11454 WILLIAMS IR, 1996, LIFE SCI, V58, P1485 WOLFF JA, 1990, SCIENCE, V247, P1465 WOLFF JA, 1991, BIOTECHNIQUES, V11, P474 WOLFF JA, 1992, HUM MOL GENET, V1, P363 WOLFF JA, 1992, J CELL SCI, V103, P1249 XIANG ZQ, 1995, IMMUNITY, V2, P129 XIONG SD, 1997, P NATL ACAD SCI USA, V94, P6352 YAMAMOTO S, 1992, MICROBIOL IMMUNOL, V36, P983 YI AK, 1996, J IMMUNOL, V156, P558 YOKOYAMA M, 1997, VACCINE, V15, P553 YOSHIMURA K, 1993, J BIOL CHEM, V268, P2300 ZIEGLER K, 1981, J IMMUNOL, V127, P1869; NR: 204; TC: 50; J9: ADVAN VIRUS RES; PG: 60; GA: BP54SSource type: Electronic(1
Reflexive regulation and the development of capabilities : the impact of the 2002/14/EC Directive on information and consultation of employees in the UK
No full textThe research evaluates the pattern of change in the field of employee representation in
the UK as influenced by the transposition and implementation of the Directive
2002/14/EC establishing a general framework for informing and consulting
employees in the European Community and to relate this analysis to the impact of
legislation in the field of labour law and industrial relations through the location of
managerial and labour practice in implementing and handling the information and
consultation arrangements. Theoretically, the thesis draws on the theory of reflexive
law (Teubner, 1993; Barnard and Deakin, 2002) and on the capabilities approach
(Sen, 1999), which has recently emerged in political economy. Empirically, it
combines textual analysis, interviews with key actors, a questionnaire survey of
companies and in-depth case studies in a few organizations in the business services
and the financial sectors. The research aims to move beyond the traditional socio-legal
concepts and methods to incorporate insights from the institutional and political
economy frames of analysis commonly deployed in the field of industrial relations,
and from its tradition of empirical enquiry rooted in field-based qualitative research
methods.
In diverging from existing UK social norms and conventions a new role for the two
sides of industry, CBI and TUC, was created that assisted in the development of the
national legislation transposing the directive and led to a re-conceptualization of the
EU-level norms, as stipulated by the directive, concerning information and
consultation of employees. Whilst the introduction of national legislation drove to
some extent the spread of voluntary arrangements, albeit at the instigation of
management, there was not much evidence that the 'standard provisions' of the UK
Regulations promoted institutional experimentation or to a new framework for a
process of learning, participation and capabilities for voice. This was down to the
nature of the legal obligations, the efficacy of the enforcement mechanisms and the
degree to which extra-legal resources, mainly trade union organization, were utilized
- …
